These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 337007)

  • 1. [Acetylsalicylic acid and gastrointestinal bleeding--a study of blood loss and absorption after intake of a gastric juice--resistant preparation].
    Arvidsson B; Magnusson A; Magnusson B; Sölvell L
    Lakartidningen; 1977 Nov; 74(46):4101-2. PubMed ID: 337007
    [No Abstract]   [Full Text] [Related]  

  • 2. Acetylsalicylic acid and gastrointestinal bleeding measurement of blood loss using a modified radioactive chromium method.
    Arvidsson B; Magnusson B; Sölvell ; Magnusson A
    Scand J Gastroenterol; 1975; 10(2):155-60. PubMed ID: 1091965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
    Portek I; Graham G; Fleming A
    Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gastric hemorrhage caused by acetylsalicylic acid--a comparison of soluble and buffered preparations].
    Isomäki H; von Essen R
    Lakartidningen; 1975 Apr; 72(15):1561-2. PubMed ID: 1079553
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastrointestinal blood loss with low dose (325 mg) plain and enteric-coated aspirin administration.
    Savon JJ; Allen ML; DiMarino AJ; Hermann GA; Krum RP
    Am J Gastroenterol; 1995 Apr; 90(4):581-5. PubMed ID: 7717315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salicylate-induced gastrointestinal bleeding: comparison between soluble buffered, enteric-coated, and intravenous administration.
    Mielants H; Verbruggen G; Schelstraete K; Veys EM
    J Rheumatol; 1979; 6(2):210-8. PubMed ID: 313448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does enteric-coated aspirin result in a lower incidence of gastrointestinal complications compared to normal aspirin?
    Walker J; Robinson J; Stewart J; Jacob S
    Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):519-22. PubMed ID: 17669925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa.
    Lanza FL; Royer GL; Nelson RS
    N Engl J Med; 1980 Jul; 303(3):136-8. PubMed ID: 6966762
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin preparation and risk of GI bleeding.
    Rao G
    J Fam Pract; 1997 Mar; 44(3):242-3. PubMed ID: 9071237
    [No Abstract]   [Full Text] [Related]  

  • 10. Safprin and gastrointestinal bleeding.
    Saldanha VF; Havard CW
    Br J Clin Pract; 1971 Apr; 25(4):169-71. PubMed ID: 5314069
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduction of aspirin-induced gastrointestinal bleeding with cimetidine.
    Welch RW; Bentch HL; Harris SC
    Gastroenterology; 1978 Feb; 74(2 Pt 2):459-63. PubMed ID: 340334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Buffered and unbuffered acetylsalicylic acid].
    Bosaeus I; Dotevall G
    Lakartidningen; 1976 Apr; 73(17):1621-2. PubMed ID: 772336
    [No Abstract]   [Full Text] [Related]  

  • 13. Single-dose evaluation of a new enteric-coated aspirin preparation.
    Paull P; Day R; Graham G; Champion D
    Med J Aust; 1976 Apr; 1(17):617-9. PubMed ID: 933973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Gastrointestinal blood loss with low-dose aspirin.
    Petroski D
    Am J Gastroenterol; 1995 Nov; 90(11):2071. PubMed ID: 7485038
    [No Abstract]   [Full Text] [Related]  

  • 15. A safe aspirin preparation.
    Brennan JB; Sripathy S
    Br J Clin Pract; 1970 Jul; 24(7):293-5. PubMed ID: 5312054
    [No Abstract]   [Full Text] [Related]  

  • 16. Salicylates in the management of rheumatoid arthritis.
    Pinals RS
    Mod Treat; 1971 Nov; 8(4):796-806. PubMed ID: 5316723
    [No Abstract]   [Full Text] [Related]  

  • 17. Coated aspirin no safer.
    Health News; 2000 Dec; 6(12):8. PubMed ID: 11142949
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioavailability studies on a buffered acetylsalicylic acid preparation.
    Ekenved G; Elofsson R; Sölvell L
    Acta Pharm Suec; 1975; 12(4):323-32. PubMed ID: 1106118
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study on a new acetylsalicylic acid/paracetamol preparation with gastric acid resistant coating (Safapryn), and on two various phenylbutazone dosages in patients with primary chronic polyarthritis as based on a new evaluation method].
    Brooks PM; Walker JJ; Lee P; Bell AM; Buchanan WW; Fowler PD; Anderson JA
    Z Rheumatol; 1975; 34(9-10):350-65. PubMed ID: 1106038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.